Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3347) 3347
Newspaper Article (73) 73
Book Chapter (33) 33
Newsletter (29) 29
Magazine Article (19) 19
Conference Proceeding (2) 2
Dissertation (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2908) 2908
tenofovir (2834) 2834
science & technology (2578) 2578
life sciences & biomedicine (2379) 2379
adenine - analogs & derivatives (1741) 1741
female (1641) 1641
male (1618) 1618
hiv infections - drug therapy (1578) 1578
adenine - therapeutic use (1442) 1442
adult (1427) 1427
infectious diseases (1375) 1375
anti-hiv agents - therapeutic use (1353) 1353
organophosphonates - therapeutic use (1195) 1195
middle aged (1071) 1071
hiv (902) 902
human immunodeficiency virus--hiv (890) 890
antiviral agents (768) 768
pharmacology & pharmacy (724) 724
antiviral agents - therapeutic use (712) 712
tenofovir - therapeutic use (693) 693
emtricitabine (689) 689
treatment outcome (647) 647
biological and medical sciences (615) 615
drug therapy (614) 614
medical sciences (607) 607
immunology (600) 600
virology (583) 583
hepatitis b, chronic - drug therapy (577) 577
drug therapy, combination (559) 559
hepatitis b (554) 554
antiretroviral drugs (542) 542
viral diseases (512) 512
aids/hiv (499) 499
lamivudine - therapeutic use (496) 496
reverse transcriptase inhibitors - therapeutic use (491) 491
anti-hiv agents - adverse effects (484) 484
anti-hiv agents - administration & dosage (482) 482
hiv infection (482) 482
viral load (472) 472
hiv infections - prevention & control (466) 466
adenine - administration & dosage (458) 458
deoxycytidine - analogs & derivatives (458) 458
human viral diseases (441) 441
adenine - adverse effects (439) 439
microbiology (439) 439
hiv infections - virology (436) 436
lamivudine (425) 425
pharmacology. drug treatments (401) 401
organophosphonates - administration & dosage (395) 395
deoxycytidine - therapeutic use (390) 390
health aspects (390) 390
young adult (386) 386
gastroenterology & hepatology (377) 377
hiv-1 - drug effects (376) 376
organophosphonates - adverse effects (369) 369
antiretroviral therapy (353) 353
hepatitis (348) 348
antibiotics. antiinfectious agents. antiparasitic agents (339) 339
viral diseases of the lymphoid tissue and the blood. aids (330) 330
virus diseases (321) 321
hiv infections - complications (318) 318
guanine - analogs & derivatives (315) 315
risk factors (314) 314
drug combinations (308) 308
clinical trials (307) 307
infections (307) 307
research (307) 307
patients (298) 298
hepatitis b virus (295) 295
dosage and administration (294) 294
analysis (287) 287
drug resistance, viral (287) 287
cd4 lymphocyte count (276) 276
guanine - therapeutic use (276) 276
adolescent (274) 274
care and treatment (273) 273
retrospective studies (272) 272
acquired immune deficiency syndrome--aids (266) 266
highly active antiretroviral therapy (266) 266
drug resistance (262) 262
aged (257) 257
antiretroviral therapy, highly active (250) 250
mutation (241) 241
abridged index medicus (235) 235
aids (234) 234
human immunodeficiency virus (234) 234
medicine (231) 231
prevention (231) 231
hiv-1 (225) 225
antiretroviral agents (224) 224
organophosphorus compounds - therapeutic use (223) 223
hepatitis b virus - genetics (220) 220
organophosphonates (220) 220
animals (216) 216
hepatitis b virus - drug effects (214) 214
prospective studies (213) 213
viruses (212) 212
hiv-1 - genetics (211) 211
adenine - pharmacology (210) 210
entecavir (203) 203
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3394) 3394
Spanish (42) 42
French (29) 29
German (29) 29
Portuguese (14) 14
Chinese (9) 9
Japanese (8) 8
Hungarian (6) 6
Korean (3) 3
Turkish (3) 3
Italian (2) 2
Polish (2) 2
Croatian (1) 1
Czech (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana
by Davey, Sonya and Ajibola, Gbolahan and Maswabi, Kenneth and Sakoi, Maureen and Bennett, Kara and Hughes, Michael D and Isaacson, Arielle and Diseko, Modiegi and Zash, Rebecca and Batlang, Oganne and Moyo, Sikhulile and Lockman, Shahin and Lichterfeld, Mathias and Kuritzkes, Daniel R and Makhema, Joseph and Shapiro, Roger
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 07/2020, Volume 84, Issue 3, pp. 235 - 241
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Cytochrome P-450 CYP3A Inducers - therapeutic use | Humans | Mothers | Cyclopropanes - therapeutic use | Cytochrome P-450 CYP2B6 Inducers - therapeutic use | Young Adult | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | Reverse Transcriptase Inhibitors - therapeutic use | Anti-Retroviral Agents - therapeutic use | Cytochrome P-450 CYP2C19 Inhibitors - therapeutic use | Emtricitabine - therapeutic use | Cytochrome P-450 CYP2C9 Inhibitors - therapeutic use | Tenofovir - therapeutic use | Risk Factors | Piperazines - therapeutic use | Benzoxazines - therapeutic use | Alkynes - therapeutic use | Pregnancy | Oxazines - therapeutic use | Botswana | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Infections - drug therapy | Pyridones - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Drug Combinations | Emtricitabine | Antiretroviral drugs | Infants | Exposure | Ribonucleic acid--RNA | Efavirenz | Antiretroviral therapy | Confidence intervals | Tenofovir | Databases | Disease transmission | Surveillance | Health surveillance | Antiretroviral agents | Human immunodeficiency virus--HIV | DNA testing | Deoxyribonucleic acid--DNA | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals
by Naggie, Susanna and Sulkowski, Mark S
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2012, Volume 142, Issue 6, pp. 1324 - 1334.e3
Gastroenterology and Hepatology | Drug Interaction | HCV | Treatment | HIV | Liver Disease | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recombinant Proteins - therapeutic use | Coinfection | Antiviral Agents - pharmacokinetics | HIV Infections - epidemiology | Humans | Hepatitis C, Chronic - etiology | Male | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Tenofovir | Deoxycytidine - therapeutic use | Drug Interactions | Homosexuality, Male | Adenine - therapeutic use | Lamivudine - therapeutic use | Anti-HIV Agents - therapeutic use | Dideoxynucleosides - therapeutic use | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Raltegravir Potassium | Substance Abuse, Intravenous - complications | Emtricitabine | Liver Diseases - virology | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Drug Administration Schedule | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Liver Diseases - prevention & control | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Pyrrolidinones - therapeutic use | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Disease Progression | Proline - therapeutic use | HIV Infections - etiology | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Antiviral agents | Medical colleges | Care and treatment | Liver diseases | Comorbidity | Drug interactions | Mortality | Development and progression | Biological response modifiers | HIV (Viruses) | Hepatitis | Protease inhibitors | Proteases | Hepatitis C virus | Hepatitis C | Health aspects | HIV infection | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
by Perez-Molina, José A, PhD and Rubio, Rafael, PhD and Rivero, Antonio, PhD and Pasquau, Juan, MD and Suárez-Lozano, Ignacio, MD and Riera, Melcior, MD and Estébanez, Miriam, PhD and Santos, Jesús, PhD and Sanz-Moreno, José, PhD and Troya, Jesús, MD and Mariño, Ana, MD and Antela, Antonio, PhD and Navarro, Jordi, MD and Esteban, Herminia, BSB and Moreno, Santiago, PhD and GESIDA 7011 Study Group and GESIDA 7011 Study Grp
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 775 - 784
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | HIV-1 | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Oligopeptides - therapeutic use | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - therapeutic use | Lamivudine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Pyridines - therapeutic use | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | HIV Protease Inhibitors - therapeutic use | Drug Therapy, Combination - methods | HIV Infections - drug therapy | Zidovudine - therapeutic use | Drug Substitution | Deoxycytidine - analogs & derivatives | Studies | Antiretroviral drugs | Heart attacks | Protease inhibitors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Clinical trials | Infections | Mutation | Drug therapy | Failure | Cost control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1—Infected Patients: Week 48 Results
by Joel E. Gallant and Ellen Koenig and Jaime Andrade-Villanueva and Ploenchan Chetchotisakd and Edwin DeJesus and Francisco Antunes and Keikawus Arastéh and Graeme Moyle and Giuliano Rizzardini and Jan Fehr and Yapei Liu and Lijie Zhong and Christian Callebaut and Javier Szwarcberg and Martin S. Rhee and Andrew K. Cheng
The Journal of infectious diseases, ISSN 0022-1899, 7/2013, Volume 208, Issue 1, pp. 32 - 39
T lymphocytes | HIV/AIDS | Antiretrovirals | Infectious diseases | RNA | HIV | Drug evaluation | AIDS | Photographs | HIV 1 | Virology | cobicistat | pharmacoenhancer | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Thiazoles - therapeutic use | Oligopeptides - therapeutic use | Anti-HIV Agents - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Pyridines - therapeutic use | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Organophosphonates - therapeutic use | Ritonavir - administration & dosage | HIV-1 - drug effects | Deoxycytidine - administration & dosage | Treatment Outcome | HIV Protease Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Adenine - administration & dosage | Organophosphonates - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Carbamates - therapeutic use | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Research | Drug therapy | HIV infection | Patient outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
by Cohen, Calvin J, Dr and Andrade-Villanueva, Jaime, Prof and Clotet, Bonaventura, MD and Fourie, Jan, MD and Johnson, Margaret A, Prof and Ruxrungtham, Kiat, Prof and Wu, Hao, MD and Zorrilla, Carmen, MD and Crauwels, Herta, PhD and Rimsky, Laurence T, PhD and Vanveggel, Simon, MSc and Boven, Katia, MD and on behalf of the THRIVE study group and THRIVE Study Grp and THRIVE study group
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Changes in bone mineral density after initiation of antiretroviral treatment with Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
by Brown, Todd T and Moser, Carlee and Currier, Judith S and Ribaudo, Heather J and Rothenberg, Jennifer and Kelesidis, Theodoros and Yang, Otto and Dubé, Michael P and Murphy, Robert L and Stein, James H and Mccomsey, Grace A
The Journal of infectious diseases, ISSN 0022-1899, 10/2015, Volume 212, Issue 8, pp. 1241 - 1249
human immunodeficiency virus | bone mineral density | protease inhibitor | inflammation | integrase inhibitor | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials
by Raffi, François and Rachlis, Anita and Brinson, Cynthia and Arasteh, Keikawus and Górgolas, Miguel and Brennan, Clare and Pappa, Keith and Almond, Steve and Granier, Catherine and Nichols, W Garrett and Cuffe, Robert Liam and Jr, Joseph Eron and Walmsley, Sharon
AIDS (London), ISSN 0269-9370, 01/2015, Volume 29, Issue 2, pp. 167 - 174
Integrase | Subgroup | Treatment efficacy | Treatment-naive | Dolutegravir | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | HIV-1 | Coinfection | Humans | Male | Viral Load | Tenofovir | Clinical Trials, Phase III as Topic | Deoxycytidine - therapeutic use | Adenine - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Dideoxynucleosides - therapeutic use | Retrospective Studies | Antiretroviral Therapy, Highly Active - methods | Raltegravir Potassium | Emtricitabine | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Pyrrolidinones - therapeutic use | Treatment Outcome | CD4 Lymphocyte Count | HIV Protease Inhibitors - therapeutic use | Randomized Controlled Trials as Topic | Regression Analysis | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Integrase Inhibitors - therapeutic use | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Drug Combinations | Index Medicus | AIDS/HIV | treatment-naive | Clinical Science | subgroup | dolutegravir | integrase | treatment efficacy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility
by George L. Melikian and Soo-Yon Rhee and Jonathan Taylor and W. Jeffrey Fessel and David Kaufman and William Towner and Paolo V. Troia-Cancio and Andrew Zolopa and Gregory K. Robbins and Ron Kagan and Dennis Israelski and Robert W. Shafer
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2305 - 2313
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Genomics | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | HIV Reverse Transcriptase - genetics | Reverse Transcriptase Inhibitors - administration & dosage | Thymidine - therapeutic use | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Thymidine - administration & dosage | Adenine - therapeutic use | HIV-1 - isolation & purification | Anti-HIV Agents - therapeutic use | Dideoxynucleosides - therapeutic use | Nucleosides - genetics | Reverse Transcriptase Inhibitors - therapeutic use | Dideoxynucleosides - administration & dosage | Drug Resistance, Multiple, Viral - drug effects | Adenine - analogs & derivatives | Drug Resistance, Multiple, Viral - genetics | Organophosphonates - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Genotype | HIV-1 - genetics | Adenine - administration & dosage | Organophosphonates - administration & dosage | Phenotype | Algorithms | Least-Squares Analysis | HIV Infections - drug therapy | Zidovudine - therapeutic use | Mutation | Index Medicus | nucleosides | RNA-directed DNA polymerase | tenofovir | Abacavir | Data processing | Thymidine | Drug resistance | Statistics | Antiviral Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A randomized, double-blind comparison of coformulated elvitegravir/ cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: Analysis of week 96 results
by Rockstroh, Jürgen K and Dejesus, Edwin and Henry, Keith and Molina, Jean-Michel and Gathe, Joseph and Ramanathan, Srinivasan and Wei, Xuelian and Plummer, Andrew and Abram, Michael and Cheng, Andrew K and Fordyce, Marshall W and Szwarcberg, Javier and GS-236-0103 Study Team
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2013, Volume 62, Issue 5, pp. 483 - 486
Emtricitabine | Tenofovir | Treatment-naive | HIV | Elvitegravir | Efavirenz | Antiretroviral therapy | Cobicistat | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Microbiology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | Confidence Intervals | Humans | Male | RNA, Viral - blood | Alanine Transaminase - blood | Thiazoles - therapeutic use | Oligopeptides - therapeutic use | Deoxycytidine - therapeutic use | Adenine - therapeutic use | HIV-1 - isolation & purification | Quinolones - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Pyridines - therapeutic use | HIV Infections - blood | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV Infections - virology | HIV-1 - genetics | Bilirubin - blood | Bone Density - drug effects | Aspartate Aminotransferases - blood | Triglycerides - blood | Creatinine - blood | HIV Infections - drug therapy | Carbamates - therapeutic use | Deoxycytidine - analogs & derivatives | Drug Combinations | Clinical trials | Antiretroviral drugs | Drug therapy | Drug testing | Human immunodeficiency virus--HIV | Indexing in process | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights